Approximately seven months after announcing its intention to acquire Korean pump-patch manufacturer EOFlow, Medtronic has abandoned the transaction.
In a 6 December 8K filing with the US Securities and Exchange Commission, the medtech giant cited “multiple breaches” of its agreements with EOFlow, meaning that the planned $738m deal will not go ahead
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Medtech Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?